Michele Mario Greco

Treatment of “Poor Risk” Acute Myeloid Leukemia with Fludarabine, Cytarabine and G-CSF (Flag Regimen): A Single Center Study

Angelo Michele Carella, Nicola Cascavilla, Michele Mario Greco et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 32 citations

Medicine, Oncology, Pharmacotherapy +16

Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression

Giovanni Rossi, Angelo Michele Carella, Maria Marta Minervini et al. · Leukemia Research · 2014 · 30 citations

Medicine, Hematology, Oncology +16

Minimal residual disease after allogeneic stem cell transplant: a comparison among multiparametric flow cytometry, Wilms tumor 1 expression and chimerism status (Complete chimerism versus Low Level Mixed Chimerism) in acute leukemia

Giovanni Rossi, Angelo Michele Carella, Maria Marta Minervini et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 29 citations

Medicine, Hematology, Oncology +17

Minimally Differentiated Acute Myeloid Leukemia (AML M0): Clinico-Biological Findings of 29 Cases

Nicola Cascavilla, Lorella Melillo, Giovanni D’Arena et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2000 · 27 citations

Medicine, Hematology, Oncology +15

Morphologically Typical and Atypical B-Cell Chronic Lymphocytic Leukemias Display a Different Pattern of Surface Antigenic Density

Giovanni D’Arena, Matteo Dell’Olio, Pellegrino Musto et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 25 citations

Medicine, Hematology, Pathology +14